Recent News

December 22, 2023 – Read Bayer’s statement on the defense verdict in the Jones Roundup trial here

November 20, 2023 – Read Bayer’s statement regarding recent verdicts in the Roundup litigation here.

November 7, 2023 – Read Bayer’s statement on the filing of post-trial motions in Caranci here.

September 28, 2023 – Read Bayer’s statement on the Directed Verdict Motion in McCostlin here.

About

This site provides information about litigation against Monsanto involving glyphosate-based products (i.e., various Roundup®-branded products.) Bayer has created this site to provide education and resources related to the litigation to media, stakeholders and others with interests relevant to this litigation.

For more information about the litigation, please contact us at info@glyphosatelitigationfacts.com.

Fast Facts on Glyphosate and
Glyphosate-Based Herbicides

  • Long history of safe use: For more than 40 years, farmers – as well as governments, gardeners, and other users – have depended on glyphosate as an efficient and cost-effective tool that can be used safely as directed to control weeds.
  • Conservation benefits: Glyphosate-based herbicides help farmers deliver crops to markets while promoting sustainable farming by reducing soil tillage, soil erosion and carbon emissions.
  • Extensive scientific backing:  The extensive body of scientific research on glyphosate-based herbicides over four decades, as well as the assessments of the EPA and other leading health regulators worldwide, support the conclusion that Roundup™ can be used safely and is not carcinogenic. Glyphosate and Bayer’s glyphosate-based herbicides are among the most thoroughly studied products of their kind – the glyphosate renewal process in the EU included a literature search of 7,000 scientific articles within the open, published literature.
  • Not carcinogenic: The 2018 publication by Dr. Gabriella Andreotti and others on the Agricultural Health Study, a large prospective cohort study sponsored by the National Institutes of Health, established that real-world exposure to glyphosate-based herbicides does not increase the risk of non-Hodgkin’s lymphoma (NHL) when adjusted for the use of other pesticides. Other studies have reached similar conclusions, including a 2022 study by epidemiologist and biostatistician Dr. Anneclaire De Roos, the Leon Agricoh Consortium meta-analysis and the North American Pooled Project studies.
  • Additionally, research by biostatistician Dr. Cristian Tomasetti, Director of the Center for Cancer Prevention at City of Hope, and Bert Vogelstein, Professor of Oncology at Johns Hopkins, demonstrates that the overwhelming majority of mutations that lead to NHL are caused by naturally occurring replication errors, and a very small portion are due to environmental or hereditary factors. Their conclusions have been widely accepted by leaders in the field of cancer prevention, and Dr. Tomasetti’s work has been cited over 12,000 times in published literature.

  • Favorable conclusions of regulators and international agencies around the world:  Leading health regulators worldwide, including the U.S. EPA, support the conclusion that Roundup™ is safe to use and glyphosate is not carcinogenic. In November 2023, the EU Commission announced that it will re-approve glyphosate for 10 years, following the favorable scientific assessments by its health and safety agencies, including the European Chemicals Agency (ECHA) and European Food Safety Authority (EFSA), which ‘did not identify any critical areas of concern’ impacting public health or the environment in their review of glyphosate in July 2023.  In June 2021, the Assessment Group on Glyphosate (AGG) completed their draft assessment of the 2020 glyphosate dossier – including the new genotoxicity studies that meet the 2016 standards – and stated ‘The AGG proposes that classification of glyphosate as for germ cell mutagenicity genotoxic or mutagenic is not justified.’

Recent Media Statements